Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Inside baby brains: new study maps first year of growth

NCT ID NCT05167565

Knowledge-focused Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 80 healthy infants from 3 to 12 months old to see how their brains and behaviors change. Researchers used safe brain scans, EEG, and eye-tracking tests at three ages. The goal was to understand normal development and how early experiences shape the brain. This study does not test any treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

80 people

The number who actually took part.

Started

Oct 2022

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

3 months and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy newborns, boys and girls, aged 3 months * Uncomplicated pregnancy and delivery, APGAR scores \>8 * Full-term birth without identified neuromotor problems at birth * No congenital or developmental anomalies affecting the brain * No reported history of neurological disorders or learning disabilities in the infants * No reported specific visual, developmental and cognitive impairment * Absence of medication having a cerebral or psychological impact * Both parents/ legal guardian must provide their consent and signature prior to participation of their infant in the study Exclusion Criteria: * Severe congenital malformation * Infants requiring a corrective surgery * Any refusal of a parent * Infants with severe impairment of the general condition and vital functions * Infants with dermatitis of the face or scalp * Infants who receive neurological treatment * Infants born pre-term (birth before 37 weeks gestation) * Infants whose mothers have significant medical conditions and/or had significant complications during pregnancy * Infants who are adopted, * Infants who have a first degree relative with autism, intellectual disability, schizophrenia, or bipolar disorder, * Infants who have any significant medical and/or genetic conditions affecting growth, development, or cognition, * Infants who have any contraindication to MRI (metallic object, surgical material like cochlear implant) * Maternal pre- eclampsia, placental abruption, maternal HIV status, and maternal alcohol or illicit drug use during pregnancy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy volunteers are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthy volunteers

Contacts and locations

Locations

  • Institut des Sciences Cognitives (ISC) Laboratoire CNRS UMR6229

    Bron, 69500, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.